Profil
Mr. Glenn C.
Andrews, CFA MBA, is President, Chairman & Chief Investment Officer at Cardinal Capital Management, Inc. (North Carolina).
He performs securities research, manages investment portfolios, co-chairman of investment committee.
He also manages day to day business operations of the firm.
He has over thirty years of financial management and investment experience.
Prior to joining Cardinal Capital Management, Mr. Andrews served as Executive Vice President, Finance and Administration and Chief Financial Officer at both Medco Research, Inc. and BioStratum, Inc. He also served as Treasurer and a corporate officer at Burroughs-Wellcome, Co. He has served as audit committee chairman and board member of the North Carolina Symphony as well as a member of the board of advisors of the Duke University Medical Heart Center.
He has also served as a board member of the Eastern North Carolina Chapter of the Juvenile Diabetes Research Foundation and as past chairman and president of the Triangle Educational Advancement Foundation.
He holds BS and MBA degrees from the University of Tennessee.
He is a CFA charter holder, a member of the CFA Institute.
He is also member and past president of the North Carolina Society of Financial Analysts.
Postes actifs de Glenn C. Andrews
| Sociétés | Poste | Début |
|---|---|---|
Cardinal Capital Management, Inc. (North Carolina)
Cardinal Capital Management, Inc. (North Carolina) Investment ManagersFinance Cardinal Capital specializes in individual equity and fixed income portfolios. The firm aims to exceed the relevant benchmark index return net of fees at significantly reduced risk (lower volatility) over a full market cycle. They apply a value-oriented approach predicated on selecting individual stocks for investment. Their investment process is entirely bottom-up. | Directeur Général | 01/05/2004 |
Anciens postes connus de Glenn C. Andrews
| Sociétés | Poste | Fin |
|---|---|---|
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Corporate Officer/Principal | - |
King Pharmaceuticals Research & Development, Inc.
King Pharmaceuticals Research & Development, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops, and licenses cardiovascular medicines and adenosine-based products | Corporate Officer/Principal | - |
Formation de Glenn C. Andrews
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
King Pharmaceuticals Research & Development, Inc.
King Pharmaceuticals Research & Development, Inc. Pharmaceuticals: OtherHealth Technology Researches, develops, and licenses cardiovascular medicines and adenosine-based products | Health Technology |
Cardinal Capital Management, Inc. (North Carolina)
Cardinal Capital Management, Inc. (North Carolina) Investment ManagersFinance Cardinal Capital specializes in individual equity and fixed income portfolios. The firm aims to exceed the relevant benchmark index return net of fees at significantly reduced risk (lower volatility) over a full market cycle. They apply a value-oriented approach predicated on selecting individual stocks for investment. Their investment process is entirely bottom-up. | Finance |
BioStratum, Inc.
BioStratum, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















